The in vitro micronucleus test (MNT) is a well-established test for early screening of new chemical entities in industrial toxicology. For assessing the clastogenic or aneugenic potential of a test compound, micronucleus induction in cells has been shown repeatedly to be a sensitive and a specific parameter. Various automated systems to replace the tedious and time-consuming visual slide analysis procedure as well as flow cytometric approaches have been discussed. The ROBIAS (Robotic Image Analysis System) for both automatic cytotoxicity assessment and micronucleus detection in human lymphocytes was developed at Novartis where the assay has been used to validate positive results obtained in the MNT in TK6 cells, which serves as the primary screening system for genotoxicity profiling in early drug development. In addition, the in vitro MNT has become an accepted alternative to support clinical studies and will be used for regulatory purposes as well. The comparison of visual with automatic analysis results showed a high degree of concordance for 25 independent experiments conducted for the profiling of 12 compounds. For concentration series of cyclophosphamide and carbendazim, a very good correlation between automatic and visual analysis by two examiners could be established, both for the relative division index used as cytotoxicity parameter, as well as for micronuclei scoring in mono-and binucleated cells. Generally, false-positive micronucleus decisions could be controlled by fast and simple relocation of the automatically detected patterns. The possibility to analyse 24 slides within 65 h by automatic analysis over the weekend and the high reproducibility of the results make automatic image processing a powerful tool for the micronucleus analysis in primary human lymphocytes. The automated slide analysis for the MNT in human lymphocytes complements the portfolio of image analysis applications on ROBIAS which is supporting various assays at Novartis.
Introduction
The assessment of chromosomal damage is an essential part in the characterisation of the genotoxic potential of a test compound. For this purpose, the induction of micronuclei (MN) in cultured cells has shown to be a sensitive and reliable alternative to the time-consuming metaphase analysis (1) . MN are generated, upon cell division, from parts of chromosomes, or whole chromosomes, which are lost from the nucleus during mitosis, and they can be specifically detected as extranuclear particles. As a measure for numerical and structural chromosome aberrations, the micronucleus test (MNT) consists of determining the frequency of micronucleated cells in a representative fraction of cells, usually at least 2000 cells per animal (in vivo) or per concentration (in vitro), to guarantee sufficient statistical power of the statistics employed.
For the assessment of genotoxicity in vivo, an automation of micronucleus scoring in rodent bone marrow through the use of image analysis has been introduced (2, 3) .
Due to the importance of early and rapid screening of new chemical entities in industrial toxicology, the need of an in vitro micronucleus assay became evident already ~20 years ago. Permanent cell lines such as V79, L5178Y or TK6 cells have been used routinely in many laboratories for conducting chromosomal aberration (CA) studies in vitro for many years. They have been found to be genetically stable and easy to handle, and thus, well suited for large-scale routine screening. Miller et al. (4) showed an excellent correlation between in vitro CA and in vitro micronucleus data in various cell lines including the V79 cell line. For CHO-K1 cells, Cellomics introduced a fully automated scanner for the detection of binucleated cells and MN in a 96-well-plate format (5) .
At Novartis, micronucleus screening started using V79 cells first and then L5178Y cells some time later. The automated sample analysis introduced by Frieauff et al. (6) further helped to establish a simple and reliable screening for genotoxic effects, more than doubling the compound screening throughput. In order to reduce the number of positive results due to the over-sensitivity of the rodent cell line compared with the results of chromosome aberration tests in human lymphocytes, p53-proficient TK6 cells were introduced in 2004 for micronucleus screening, after an extensive validation using both the CA as well as MNT results in human lymphocytes (unpublished data).
Initially designed as an in vitro technique for biological dosimetry of exposure to radiation or other forms of genotoxic agents, Fenech and Morley (7, 8) described the cytokinesis block method for micronucleus scoring in human lymphocytes. Due to the addition of Cytochalasin B, the micronucleus scoring is performed separately in binucleated cells in interphase, which have undergone one mitotic cycle, and mononucleated cells. Detailed criteria were published for scoring MN in lymphocytes (9, 10) .
Based on different preparation, fixation and staining techniques, several groups had approached the automation of the MNT in binucleated human lymphocytes using microscopic image analysis with an automated detection of binucleated cells and MN therein during the 1990s (11) (12) (13) (14) (15) . They had reported the correct detection of binucleated cells in the range of 63-88% with a micronucleus detection rate between 51% and 89% (16) .
More recently, Schunck et al. (17) and Varga et al. (18) described their experience with the Metasystems Metafer MNscore system and found a high correlation between visual and automatic counting, but also a large drop for the automated MN counts (35% of the visual MN count). Their algorithm assumes that two similar nuclei are representing a bi-nuclear cell characterised by a defined region of interest, without including information on the cytoplasm for nuclear 4'-6-diamidino-2-phenylindole (DAPI) staining as suggested by Varga et al. (18) . In addition, their system may also be used to analyse non-fluorescently stained slides (19) . Using the same Metafer system but following a modified slide preparation protocol for radiation biodosimetry for in vitro studies, Willems et al. (20) reported a micronucleus detection rate in binucleates of ~87%. According to the Metasystems information (http://www.metasystems-international.com), additional cytoplasmatic staining allows the assessment of the cytokinesis-block proliferation index.
Decordier et al. (16, 21) published their experience with the IMSTAR PathFinder system, another commercially available system for the automated MN analysis in human lymphocytes. Unlike the Metafer approach that substitutes the unstained cytoplasm by a defined region of interest, IMSTAR uses the stained cell as starting point for the detection. Using a preparation technique to optimise cell density and dispersion, Giemsa-stained cells were classified as mono-, bi-and polynucleated which is an important prerequisite to assess the division index (DI) for in vitro cytotoxicity assessment. The MN analysis revealed a good correlation with visual counting but a lower MN frequency (69% of visual MN count). An overview over published approaches for automated micronucleus detection and a comparison of the results is given by Decordier et al. (16) and Rossnerova et al. (22) , focusing on the experience with commercially available micronucleus systems, especially PathFinder and Metafer.
This article describes the technical aspects of the automated slide analysis procedure for distinguishing between mono-, biand polynucleated cells, and detection of MN therein using Robotic Image Analysis System (ROBIAS), a proprietary Novartis development for automated image analysis. Unlike the previously described Metasystems and IMSTAR systems, ROBIAS is not commercially available. However, the image analysis algorithm process for correct identification and segmentation of cytoplasm, nuclei and MN together with the validation results obtained are described in sufficient detail (supplementary material, available at Mutagenesis Online) to support development of a similar system, potentially useful for the integration into available scanners or slide handling devices.
Materials and methods
The human lymphocyte MN assay Test compounds. Carbendazim (MBC, CAS no. 10605-21-7) was purchased from Sigma-Aldrich Chemie (Steinheim, Germany) and dissolved in dimethyl sulphoxide (DMSO). Cyclophosphamide (Baxter AG, Volketswil, Switzerland, CAS no. 50-18-0) was dissolved in 0.9% NaCl solution prior to culture treatment in the presence of S9 metabolic activation. All Novartis test compounds were synthesised in-house as drug candidates. The chemicals were dissolved either in Roswell Park Memorial Institute (RPMI) medium or DMSO. When DMSO was used, the final concentration in the culture medium was 1%. In the absence of cytotoxicity, all compounds were tested up to 10 mM or 5 mg/ml, whichever was lower.
Cells and culture condition. Heparinised blood from healthy volunteers was used. Cells were cultivated at 37°C in RPMI medium containing 20% foetal bovine serum, 1% penicillin/streptomycin and 37.5 µl/ml phytohaemagglutinin (PHA). Cytochalasin B (6 µg/ml) was added 44 h after inoculation and cultures were harvested at 72 h. Cells underwent cold hypotonic treatment (0.075 M KCl) and were immediately centrifuged and fixed three times with fixative (methanol:acetic acid, 3:1) supplemented with 1% formaldehyde for the first fixation. The fixed cells were dropped onto clean microscope slides (two slides per culture), air-dried and stained with 2% Giemsa in a 5-mM Na 2 HPO 4 -5-mM NaH 2 PO 4 buffer and mounted in Terpex (LabForce AG, Nunningen, Switzerland). Test compounds were added at 24 h after PHA stimulation and lasted for 3 h ±S9 metabolic activation or for 48 h without S9.
Metabolic activation system. Rat liver S9 microsomal fraction was used for metabolic activation (final S9 mix concentration in the culture medium: 10%). S9 mixture was prepared in distilled water and contained 10% of S9 microsomal fraction (Trinova Biochem Gmbh, Giessen, Germany), glucose-6-phosphate 1.25 mg/ml (Roche Diagnostics, Mannheim, Germany, CAS no. 3671-99-6), nicotinamide adenine dinucleotide phosphate, disodium salt 0.53 mg/ml (Merck, Darmstadt, Germany, CAS no. 24292-60-2), potassium chloride 2.24 mg/ml (Merck, Darmstadt, Germany, CAS no. 7447-40-7), sodium hydrogen carbonate 1.5 μg/ml (Merck, Darmstadt, Germany, CAS no. 144-55-8) and 10% Hanks Balanced Salt Solution 10× (Gibco, Invitrogen, Auckland, New Zealand).
Visual slide reading. For each substance, at least three concentrations (two cultures per concentration) and 2000 binucleated cells per concentration were analysed using a 100× oil immersion objective. A total of 500 cells/culture were scored to determine the division index DI (a cytotoxicity parameter) and 1000 binucleates analysed for MN induction. MN in mononucleates were also determined using binucleates count as the basis. A micronucleus was defined as a particle surrounded by distinct borders, with a size between 1/16 and 1/3 of the main nucleus and similar staining, and residing inside the cytoplasm. MN overlapping the main nucleus were not counted. Every micronucleus was focused individually in order to exclude small dye particles. MN in mononucleated cells were counted separately from those in binucleated cells. Cells in mitosis were counted separately. In general, the criteria defined by HUMN (9,10) were applied.
For the comparative slide analysis by ROBIAS versus visual scoring, 25 experiments with 12 proprietary Novartis compounds were conducted by a single lab technician who also performed the visual slide reading. For the additional evaluation of concentration series of cyclophosphamide and carbendazim, two lab technicians performed an independent visual analysis of the slides, to compare with the automated analysis and assess the inter-individual agreement (see Results section).
Cytotoxicity. For cytotoxicity assessment, the Relative Division Index (RDI) (23), also called Replicative Index (24) Statistical analysis. Statistically significant differences between controls and treated samples were determined with the chi-square test (95% confidence limit is used). A compound was considered positive for the MN induction if it induced a reproducible statistically significant increase in the number of micronucleated binucleates (MNCB).
ROBIAS system ROBIAS (Robotic Image Analysis system) is built from an electronically driven Leica DM RXA/2 microscope mounted with a SONY DXC-390 colour camera that is linked to the host PC with a Matrox Meteor-II/MC frame grabber ( Figure 1) . A connected robotic slide feeder (EPSON) supports automatic placement of up to 130 slides on the microscope's stage for processing which is performed by using in-house (Novartis) custom-developed image analysis algorithms based on the Matrox Imaging Library MIL V9.
Graphical user interfaces were developed using Visual Basic, whereas image processing and communication with the peripheral devices was programmed in Visual C++.
At Novartis, the ROBIAS system was designed as a multi-purpose platform to support the automated analysis for a variety of cytogenetics assays such as the MNT in vivo (rodent bone marrow preparations) and in vitro (several cell lines), comet assay in vivo (various organs) and in vitro (25) , and metaphase finding for the chromosome aberration test. It is also the platform for applications from histopathology (automatic proliferation assessment in different organ sections), morphometric analyses for tissue samples or real-time analysis of the beating-rate frequency of cardiac myocytes. The ROBIAS system is proprietary to Novartis and currently not commercially available.
The software for all image analysis applications was developed in-house. For pattern recognition applications such as the MNT in human lymphocytes, it consists of three separate programs: a data input program for the specification of the slides to be analysed, an automatic measurement program and a relocation program enabling the operator to retrieve all detected patterns and skip possible artefacts which the system had erroneously counted as MN (rejection of false positives).
For the human lymphocyte MNT, a Leica HC PLAN APO 20×/0.70 objective was used for the slide scanning process, whereas a Leica HCX PL APO 40×/0.85 objective with additional 1.6× subsequent magnification was used for the object relocation part.
Image analysis process
The evaluation task consisted of counting 1000 binucleated cells per slide. Mono-and polynucleated cells as well as mitotic figures such as metaphases should also be handled and counted correctly. Cellular or nuclear debris, cells with insufficient cytoplasm-i.e. less than a minimum of (cytoplasm + nucleus)/ nucleus area ratio-or those touching the measurement frame at the right or lower edge, were excluded from counting. For the micronucleus finding, only MN located within cells that were identified and counted according to the HUMN acceptance criteria (10) were considered. The system was able to distinguish between single and multiple MN in a cell, thus allowing to count micronucleated cells and to differentiate according to the number of detected MN per cell. The general underlying concept for image analysis algorithms was based on the theory of 'Mathematical Morphology' (26) (27) (28) (29) , providing the mathematical background for many specific segmentation tools and transformations.
Determination of a 'valid' image for analysis. For the image evaluation, scanning of overlapping image frames in a spiral scanning mode, starting at the centre of a specimen, was performed. The overlap was chosen in order not to skip larger cells that would touch the frame of adjacent, non-overlapping images and, therefore, would have been processed inadequately. For each stage position, a digital 736 × 570 image with 256 grey values from each of the colour camera's red, green and blue colour channels was used. The green channel's grey image output was used as standard working image, due to the bluish staining colour (Giemsa) of the specimen yielding the highest object/background contrast. After autofocus and image capture (Figure 2 ), the image analysis to determine the 'validity' of the current image field consisted of the following processing steps:
(i) Only cells and nuclei residing within a rectangular measurement frame ( Figure 5 ) were considered. In addition, objects touching the upper or lefthand edge of the measurement frame were included, to guarantee the analysis of all cells but prevent objects from a double analysis after moving to the neighbouring image field for which the upper or left measurement frame edges of the previous image would become lower (resp. right-hand) frame edges in the new image with touching objects now to be skipped. (ii) Computation of the background grey value and rejection of the current image if the proportion of too bright or too dark regions was too large.
The first step of the analysis of a suitable image consisted of the detection of nuclei and mitotic figures (number of metaphases used for the computation of the mitotic index). A detailed description of the algorithm to detect valid nuclei and metaphases can be found in supplementary material (available at Mutagenesis Online).
'False positive' artefacts, i.e. objects erroneously detected as metaphases, were rejected by using the pattern relocation program which was used for the visual control of detected MN. By attaching the stage coordinate list of detected metaphases to the coordinate list of MN, the retrieval was easy and straightforward. Figure 3 shows the result for the detection and classification of valid nuclei and metaphases.
Cell segmentation and classification. Although the nucleus detection was rather simple to achieve, the correct identification of cells (cytoplasm) proved to be more of a challenge due to varying staining intensities even within the same image field. Valid cells could be stained very intensely, whereas neighbouring cells had a very bright and faintly stained cytoplasm. In addition, touching cells with no clearly visible edge between them were observed quite frequently. A detailed description of the cell segmentation and classification is available in supplementary material (available at Mutagenesis Online). Finally, an image of valid cells containing nuclei which were classified as mono-, bi-or polynucleated cells was obtained. Figure 4 shows the final cell classification result, based on the previous detection and classification of valid nuclei and metaphases.
Micronucleus detection
Using various techniques and their combinations, micronucleus detection consisted of an iteration of morphological transformations and refinement of specific selection criteria for segmentation, followed by the classification of the segmented micronucleus candidates based on 22 morphometric and relational features. For all parts of the detection algorithm, preset fixed (empirically determined but adjustable) values from a parameter file were used. Supplementary   Fig. 1 . The ROBIAS system with a Leica DM RXA2 microscope and EPSON slide handling robot with slide racks. For the original image displayed in Figure 2 , Figure 5 shows the final overall image analysis result, consisting of the detection of valid cells with nuclei, metaphases, and MN in counted cells.
Results

Determination of the micronucleus frequency in binucleated cells through automatic and visual scoring
For a first validation approach of the automatic image analysis for micronucleus screening, this scoring method was carried out in parallel with visual scoring in a series of 25 experiments, using 12 proprietary compounds of Novartis. For both methods, a compound was considered to be positive if it induced a reproducible statistically significant increase in the number of MNCB.
In all cases, two slides-for two replicates per concentration-were evaluated, with a counting limit of 1000 binucleated cells per replicate.
For all experiments performed, a good quantitative correlation between visual scoring and micronucleus detection by image analysis was found for counting and distinguishing cells as mono-, bi-and polynucleated cells (resulting in the DI value), as well as for micronucleus detection in binucleated cells. In all cases, identical overall conclusions were drawn from the data obtained by image analysis and by visual slide scoring. Table I and supplementary Tables TS II-XII (available at Mutagenesis Online) show the comparison of visual and automatic micronucleus scoring for the experiments conducted for the profiling of the 12 compounds. All results shown were obtained using the object relocation program to exclude falsepositive events.
Compound 7 was the only compound in the series of 12 that was judged to be genotoxic based on the positive data for both visual and automated analyses observed for treatment without S9 (supplementary Table TS VIIb, available at Mutagenesis Online). All other compounds were concluded to be devoid of a genotoxic potential, irrespective of the analysis method (visual assessment or automated slide analysis).
In order to assess the sensitivity of the ROBIAS analysis, we analysed concentration series of known genotoxins as well. Therefore, an additional comparison for a series of eight concentrations of the clastogen cyclophosphamide (CP, 3-h treatment in the presence of S9) and seven concentrations of the aneugen carbendazim (MBC, 44-h treatment without S9) was conducted by two different examiners. The ROBIAS microscope (Leica DM RXA/2) with the optical setting employed for the relocation of MN (40× objective with additional 1.6× magnification) was used for visual slide analysis, conducted in the same region of image fields as was scanned by ROBIAS. No direct field-by-field comparison of visual versus automated micronucleus analysis was possible due to the different optical magnification settings for the two approaches.
The good correlation between visual (M1, M2) and automatic (ROBIAS) cell classification for cyclophosphamide, described through the RDI value at each concentration, is visible from Figure 6 , with an established linear regression RDI_ROBIAS = 0.994 × RDI_M1 with a coefficient of determination R 2 = 0.974, and RDI_ROBIAS = 0.962 × RDI_M2 with a coefficient of determination R 2 = 0.961. Similarly, for MBC, Figure 7 shows the correlation between visual and ROBIAS classification, with the linear regression expressed by RDI_ROBIAS = 1.006 × RDI_M1, with a coefficient of determination R 2 = 0.971, and RDI_ROBIAS = 0.982 × RDI_M2 with a coefficient of determination R 2 = 0.985. Regarding micronucleus detection in binucleated cells, Figures 6 and 7 give evidence for the sensitivity of the ROBIAS system to detect MN compared with visual counting. identical (16.45%), whereas the second visual count (M2) yielded only 14.30%. The linear regression for visual versus ROBIAS micronucleus detection in binucleated cells for MBC was MN_ROBIAS = 0.946 × MN_M1, with a coefficient of determination of R 2 = 0.990, and MN_ROBIAS = 1.047 × MN_ M2 with R 2 = 0.972. As a well-known aneugen inducing mitotic slippage (30), the micronucleus induction by MBC in mononucleated cells was also evaluated (Figure 8 ). Again, a very good correlation between visual and automated micronucleus analysis could be established, with a maximum difference of <10%, and a linear regression of MN_ROBIAS = 0.934 × MN_M1, with a coefficient of determination of R 2 = 0.998, and MN_ ROBIAS = 0.956 × MN_M2 with R 2 = 0.997. For both CP and MBC, the variation in the automated analysis result (after relocation) for the two replicates of each concentration was equal or smaller than the respective variation in each of the visual analysis results (M1 or M2) of the corresponding slides (data not shown).
Several reasons for missing MN by automatic scoring were identified:
(i) touching nucleus and micronucleus prevented the detection of a micronucleus; (ii) too weakly stained MN which could not be segmented correctly; (iii) MN touching or overlapping Giemsa-stained cellular or nuclear debris; (iv) failure of correct identification of a binucleated cell and, consequently, skipping of pertinent MN; (v) MN falling outside the established classification rules and, therefore, was rejected.
Since the false-negative rate was very low (usually <10%), no quantitative data on the prevalence of the listed different reasons for missing MN can be provided, without having the possibility of checking missed true MN with a reasonable effort during the fully automated scoring. On average, ~5% (between 3.38% and 6.27%, individual data not shown) false positives were observed, where 'false positive' was defined as the ratio of number of cells without MN, while an object (artefact) had been detected and counted by ROBIAS. This 'false positive' rate of cells should not be mixed with the reported value of 30.8% of objects that had been detected but were visually classified 'artefacts' during the MN classificator's testing phase (see (7) in the Micronucleus detection section in supplementary, available at Mutagenesis Online) where no association with the underlying cell types (mono-, bi-and polynucleated) had been made.
False positives were not found to be a problem, due to the relocation program which allowed the final control step for the rejection of artefacts through quick visual inspection of the revisited objects. Since MN in mononucleated cells were also detected and handled separately, by omitting mononuclear cells and only focusing on binucleates it would be possible to further reduce the number of false positives.
It should be noted that due to variations in the slide preparation quality, staining differences and compound influence on the cellular structure, the artefact control is deemed to be a necessary and not just optional part of the automatic scoring of the in vitro MNT.
Evaluation time
Visual scoring of one slide, i.e. classification of 500 cells into mono-, bi-and polynucleated cells, and counting the number of micronucleated cells in a total of 1000 binucleated cells, usually took between 30 and 90 min, depending on the extent of cytotoxicity and proportion of binucleated cells.
Similarly, for automatic image analysis, the evaluation time for one slide was strongly dependent on the density of cells on the slide (number of cells per image field) and cytotoxicity-mediated percentage of binucleates. The optimum cell density was 10-15 cells per image field. If there were >20 cells per field, the separation of clustered cells proved to be too time-consuming or even impossible (with the consequence that such clusters carrying too many nuclei were skipped from further analysis), and less than five cells per field meant that a high number of image fields had to be auto-focused and evaluated.
In the case of a high number of micronucleus candidates, such as staining particles, small membrane parts, DNA fragments, or other contrasted small objects, more steps in the micronucleus finding algorithm had to be passed in order to eliminate these artefacts. However, the micronucleus detection part of the image analysis algorithm was not found to be the main reason for elongated computation time, but rather the iteration of segmentation loops for nucleus and cell segmentation.
The typical evaluation time for a standard slide with average cell density and not too many background particles was 1.5-2.5 h for scoring of 1000 binucleated cells, with up to 4 h for very cytotoxic concentrations with a low proportion of binucleated cells.
For a standard experiment with 3 h +S9 treatment and 44 h −S9 continuous treatment, the analysis of four concentrations plus concurrent positive and solvent control (2 cultures/slides per concentration), equivalent to an analysis of 24 slides with 1000 binucleated cells per slide, usually took <65 h (over-weekend analysis). The time needed for the artefact control (micronucleus relocation) was ~5 min per slide, i.e. ~2 h for all 24 slides in one run so that planning of repeat experiments on the basis of the analysis data was possible prior to starting the new experimental cycle in the same week, whereas a full week was needed for visual slide analysis if no automated system was used.
Discussion
Use of the MNT in human lymphocytes at Novartis
The chromosome aberration test in human lymphocytes had become the preferred regulatory cytogenetics assay in mammalian cells at Novartis for the registration of new drugs ~10 years ago. The MNT in vitro was used as a screening assay to predict the outcome of the regulatory chromosome aberration test (4, 6, 31) .
The MNT in human lymphocytes involves various cell types (mono-, bi-and polynucleates) as well as the rather unspecific Giemsa staining which makes visible a lot of cellular and nuclear debris as well as staining particles, with the consequence that no automated analysis was possible until recently. Therefore, the MNT in human lymphocytes-although considered to be 'gold standard' for the prediction of the chromosome aberration test-never made it as a screening assay. Instead, its visual version was used to confirm or overrule weakly positive MNT results in TK6 cells for which the automated analysis had been an integral part to guarantee a sufficiently high throughput at Novartis. Only recently, after the new ICH guideline (32) was adopted, it was decided to use the MNT in human lymphocytes as regulatory cytogenetics test in vitro for the registration package of new drug candidates to support clinical studies, replacing the chromosome aberration test.
By cutting down the time to conduct a study by 50%, automated analysis will further help to process an even higher number of compounds in the MNT in human lymphocytes.
Image analysis using ROBIAS
From an image analysis point of view, the advantage of using the slide preparation protocol described before was the segmentation of valid cells, nuclei and MN for Giemsa-stained samples, without having to worry about fading fluorescence dyes. One single staining for DNA and employment of a colour CCD camera seemed clearly preferable over the image analysis approaches on human lymphocytes (see Introduction section for a review) where a grey value camera with one or moretwo according to (11)-interference filters was used. A 20× objective for good visualisation of the cells, the nuclei and MN at the same time proved to be sufficient for scanning, whereas other groups (13) (14) (15) 33) had used two different magnifications for cell and micronucleus detection. Decordier et al. (16, 21) had only used a 10× objective which they claimed was not the reason for the reduced detection rate of ~69%, however, slight variations in the contrast of the same image field after repetition of the autofocus could easily flip the value at a single pixel between 'hit' or 'missed'. To enable the morphometric description of a segmented object, its size should always be above the smallest unit in the digitisation grid (digital resolution). For the visual rejection of 'artefacts', a 40× objective with subsequent 1.6× magnification was chosen for ROBIAS to obtain the maximum confidence on the quality of the object to be accepted or rejected as MN. Here it is emphasised that a 'Relocation' program to control and adjust for false positives is considered to be an important and integral part of the MN application. For this purpose, the system stores the stage coordinates of each object classified as micronucleus during the automatic scanning and detection process. Using the interactive post-analysis program 'Relocation', the user can then judge on the basis of the visual appearance of each object (movement of the microscope stage to the object's coordinates with display on the screen) and, by de-selection, exclude it from the list of true MN. This object relocation usually takes only a couple of minutes per slide, but adds significant value to the system.
The correct detection of >90% of the MN can be considered superior to the image analysis results of the other groups, where only Vral et al. (13) and Verhaegen et al. (33) had reported similar values (89%) of correctly identified MN.
Making extensive use of the stained cytoplasm to work on the cell as basis for the detection of nuclei and MN, the ROBIAS image analysis follows a similar approach as the IMSTAR system (16), whereas the Metasystems Metafer analyser, assuming DAPI-stained samples, completely ignores any cytoplasm. According to the authors (17), adjustment of classifiers according to the specific lab protocol supports the optimisation of the system's detection rate. While both the Metafer and the IMSTAR systems were developed to support biomonitoring and radiation dosimetry with the main scope of detecting binucleated cells and MN therein, the ROBIAS micronucleus analysis software was developed to cope with effects of strong cytotoxicity (discrimination of cellular debris), to detect mono-, bi-and polynucleated cells as well as mitotic figures (metaphases), and determine artefacts from true MN and link them with the different cell types.
In general, the correct segmentation of cells and MN while keeping the false-positive rate low proved to be a critical and time-consuming process for all image analysis approaches, independently of the type of cells employed.
A series of tests for comparing visual scoring with automatic image analysis showed that there was a very good concordance between the results obtained with both methods. Using identical criteria for a positive effect in the assessment of the data obtained by visual or automatic slide reading, the conclusions were the same in 24 out of 25 experiments, irrespective of the method used. In one case (compound 7, see supplementary Thus, automatic image analysis showed a high degree of reliability, and well-known mutagenic compounds were easily detected. Weak effects were detected equally well by image analysis and by visual slide scoring (Figures 6-8 , Table I and  supplementary Tables TS II-XII, available at Mutagenesis Online).
Since slide reading by image analysis is a fully automatic process, 24 slides (counting 1000 binucleates per slide) can be analysed over the weekend which allows repeat experiments to be conducted during the following week if necessary. Less than 2 h are required for slide loading and artefact control. Thus, the throughput per technician could be doubled using ROBIAS compared with visual scoring where a full week was used for slide analysis, following the experimental week. While it is acknowledged that other systems based on scanning using a 10× objective may be faster, the increased sensitivity combined with the possibility to eliminate false-positive events through object relocation and the fact that more than one ROBIAS system can be used in parallel have encouraged us at Novartis to use the described system setup.
In summary, automatic image analysis using ROBIAS has proved to be an excellent system for reliable and objective micronucleus scoring for the MNT in human lymphocytes. Through discrimination of mono-, bi-and polynucleated cells as well as mitotic figures, the system was able to determine the DI as a marker of cytotoxicity. Furthermore, the correct association of detected MN to mono-and binucleated cells was possible, assuring the correct assessment of micronucleus induction in proliferating cells. The software package, consisting of programs for slide specific information entry, automatic detection and relocation of detected objects for artefact rejection, has shown to be efficient and reliable and was easy to familiarise with even for novices on the image analysis area. The system's usage is not restricted to the analysis of slides processed at Novartis labs but ROBIAS is equally suited for the analysis of samples from any lab following the preparation and staining procedure as described in the Materials and methods section.
Based on the results presented, it was decided to replace visual slide analysis by automatic slide reading in all our in vitro micronucleus experiments in human lymphocytes.
It is well recognised that the system's current capability is limited to the detection of cells, nuclei and MN, without quantifying other events such as nucleoplasmic bridges, nuclear buds, necrotic or apoptotic cells which would complement the information on the cellular and genetic health status. Including the detection of such events, a very powerful automated 'cytome' system (34) could be developed in the future. Tables TS II-XII  are available at Mutagenesis Online.
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